Trulieve Cannabis (TRLV) EBT (2020 - 2026)

Trulieve Cannabis (TRLV) has reported EBT for 7 consecutive years, with $25.2 million the latest figure, recorded in Q1 2026.

• In Q1 2026, EBT rose 24.07% year-over-year to $25.2 million; the TTM figure through Mar 2026 stood at $96.4 million (up 209.91% YoY), while the FY2025 annual figure was $91.5 million, up 114.15% from the prior year.
• EBT came in at $25.2 million for Q1 2026 at Trulieve Cannabis, up from $2.9 million in the prior quarter.
• The five-year high for EBT was $38.9 million in Q2 2025, with the low at -$308.2 million in Q2 2023.
• Average EBT over 5 years is -$8.7 million, with a median of $13.0 million recorded in 2022.
• Across the five-year window, EBT plunged 1265.17% in 2023 and surged 2644.5% in 2024, its largest moves.
• Year by year, EBT stood at -$17.6 million in 2022, then soared by 150.09% to $8.8 million in 2023, then tumbled by 246.25% to -$12.9 million in 2024, then surged by 122.79% to $2.9 million in 2025, then surged by 757.53% to $25.2 million in 2026.
• According to Business Quant data, EBT over the past three periods registered $25.2 million, $2.9 million, and $29.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.